NEW YORK, NY / ACCESSWIRE / December 3, 2024 / Investor Summit Group, committed to advancing the MicroCap and SmallCap investment community, announces that the November 21, 2024 Winter Investor Summit Virtual Conference presentations are now available for on-demand viewing.

EDEN PRAIRIE, MN / ACCESSWIRE / November 13, 2024 / NeuroOne Medical Technologies Corporation (Nasdaq:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will be participating in the Virtual Investor Summit Microcap Event. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.

NMTC stock results show that NeuroOne Medical Tech met analyst estimates for earnings per share but missed on revenue for the third quarter of 2024.

Given the high bar to developing good neuroscience drugs, firms that do so will likely succeed. Here are three top biotech stocks to buy now. 

These neurotech stocks stand at the cutting edge of healthcare, but early entrants in new fields tend to be long-term winners.

NMTC stock results show that NeuroOne Medical Tech missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

--News Direct--

--News Direct--

NeuroOne Medical Technologies (NASDAQNMTC) is committed to improving surgical care options and outcomes for patients suffering from neurological disorders including epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries. The company’s minimally invasive and high-definition/high-precision solutions offer combination diagnostic and therapeutic functions for EEG recording, tissue ablation, as well as potentially for deep brain stimulation. Along with three FDA-cleared product families, Evo(R) Cortical Electrodes, Evo(R) sEEG Electrodes, and the OneRF(R) Ablation System, the company is engaged in R&D for drug delivery and spinal cord stimulation programs and is exploring potential applications of its medical technology using artificial intelligence. For more information, visit the company’s website at www.nmtc1.com .

--News Direct--

Companies Reporting Before The Bell • LCI Indus (NYSELCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million.

NMTC stock results show that NeuroOne Medical Tech beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.

Companies Reporting Before The Bell • Live Ventures (NASDAQLIVE) is estimated to report earnings for its fourth quarter. • Jabil NYSE:JBLNYSEJBL)

It's time to dive into the biggest pre-market stock movers as we start the trading week on Monday with the hottest coverage!

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQSGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.